Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OTX-DP in chronic allergic conjunctivitis
NCT02445326Phase 3Completed
- Sponsor
- Ocular Therapeutix
- Start
- Apr 2015
- Primary completion
- Aug 2015
- Modality
- Orthosteric Ligands
01
Overview
A Phase 3 trial of dexamethasone in allergic conjunctivitis (AC), sponsored by Ocular Therapeutix. Started Apr 2015; status: completed.
02
Drugs
dexamethasone
03
Conditions
allergic conjunctivitis (AC)
Beyond the preview
Go deeper on NCT02445326.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02445326.